Vizora日本語

SymBio PharmaceuticalsSymBio Pharmaceuticals Limited4582東証グロース医薬品FY ending Dec 2025, consolidated, J-GAAP

SymBio Pharmaceuticals FY ending Dec 2025 results

SymBio Pharmaceuticals brought in ¥1.31B in revenue.

It lost about ¥340 for every ¥100 of sales at the operating level.

Revenue changed -46.7% from the prior year.

What changed from last year

FY ending Dec 2024 → FY ending Dec 2025

Revenue
-46.7%¥2.45B → ¥1.31B
Gross profit
-49.4%¥1.87B → ¥947.3M
Operating income
Loss-¥3.88B → -¥4.44B
Net income attributable to owners
Loss-¥3.83B → -¥4.78B
Operating cash flow
Loss-¥3.42B → -¥4.58B

Where the money goes

FY ending Dec 2024 → FY ending Dec 2025

Where ¥100 of sales goes

For every ¥100 SymBio Pharmaceuticals sells, how much goes where, and how much is kept.

FY ending Dec 2025
Cost of sales
¥28
SG&A
¥412
Operating loss
¥340
Net loss
¥365

Annual margin trends

Gross margin72.4%
FY ending Dec 2020: 29.0%29.0%FY ending Dec 2021: 70.3%70.3%FY ending Dec 2022: 75.9%75.9%FY ending Dec 2023: 78.9%78.9%FY ending Dec 2024: 76.4%76.4%FY ending Dec 2025: 72.4%72.4%FY20FY21FY22FY23FY24FY25
Operating margin-339.6%
FY ending Dec 2020: -150.9%-150.9%FY ending Dec 2021: 12.3%12.3%FY ending Dec 2022: 19.6%19.6%FY ending Dec 2023: -14.5%-14.5%FY ending Dec 2024: -158.1%-158.1%FY ending Dec 2025: -339.6%-339.6%FY20FY21FY22FY23FY24FY25
Net margin-365.3%
FY ending Dec 2020: -136.9%-136.9%FY ending Dec 2021: 24.6%24.6%FY ending Dec 2022: 11.8%11.8%FY ending Dec 2023: -35.1%-35.1%FY ending Dec 2024: -156.3%-156.3%FY ending Dec 2025: -365.3%-365.3%FY20FY21FY22FY23FY24FY25

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第21期(2025/01/01－2025/12/31)

    ID S100XNE52026-03-24Open

  • EDINET (FSA Japan)

    有価証券報告書－第20期(2024/01/01－2024/12/31)

    ID S100VGDJ2025-03-25Open

  • EDINET (FSA Japan)

    有価証券報告書－第19期(2023/01/01－2023/12/31)

    ID S100T3FG2024-03-22Open

  • EDINET (FSA Japan)

    訂正有価証券報告書－第18期(2022/01/01－2022/12/31)

    ID S100QG6E2023-03-24Open

  • EDINET (FSA Japan)

    有価証券報告書－第17期(令和3年1月1日－令和3年12月31日)

    ID S100NPZC2022-03-29Open

  • EDINET (FSA Japan)

    有価証券報告書－第16期(令和2年1月1日－令和2年12月31日)

    ID S100L0KX2021-03-24Open

Extracted from XBRL: 40

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image